March 7th 2023
About 60% of dual vapers experienced depression and 52% experienced anxiety, according to findings from a survey of over 2500 youth and young adults.
February 9th 2023
Key Takeaways for the Management of MDDFebruary 9th 2023
Carmen Kosicek, MSN, PMHNP-BC; Charles Montano, MD; and Gus Alva, MD, DFAPA, provide take-home messages for the management of patients with MDD and other depressive disorders.
Impact of Different MDD Classes of Treatment on Time to ResponseFebruary 2nd 2023
Charles Montano, MD, and Carmen Kosicek, MSN, PMHNP-BC, comment on the impact of various classes of MDD treatments on time to achieve goals and/or response.
Current Challenges With MDD Treatment OptionsFebruary 2nd 2023
Carmen Kosicek, MSN, PMHNP-BC, leads a discussion on the level of satisfaction for both patients and providers with currently available MDD treatment options, barriers to access, and the impact of residual symptoms on a patient’s quality of life.
Monitoring Recommendations for MDDJanuary 19th 2023
Charles Montano, MD, and Carmen Kosicek, MSN, PMHNP-BC, provide advice regarding monitoring for adverse events and compliance with different classes of MDD treatment and review suggestions for follow-up and special patient populations.
Perception of MDD in the Healthcare CommunityJanuary 19th 2023
Experts in psychiatry share their thoughts on the perception of MDD within the healthcare community and the implications of this condition being viewed as chronic vs episodic.
Depression and Comorbid Health ConditionsDecember 22nd 2022
Carmen Kosicek, MSN, PMHNP-BC, and Charles Montano, MD, comment on the interplay between depression and other comorbid psychiatric and medical health conditions as well as the economic impact of MDD.
Impact of MDD Episode Duration and RecurrencesDecember 22nd 2022
Charles Montano, MD; Carmen Kosicek, MSN, PMHNP-BC; and Gus Alva, MD, DFAPA, review the impact of the duration of MDD episodes and goals of managing episode recurrences.
Women Found "Significantly" More Likely to Experience Long COVID, Disaggregated Research is Essential, Investigators SayJune 23rd 2022
A literature review comprising ~1.3 million patients infected with SARS-CoV-2 reveals women are 22% more likely vs men to develop long COVID, yet treatment is no different.